Medicamen Organics
add_icon

Medicamen Organics

22.15
-0.80
(-3.49%)
Market Cap
25.92 Cr
PE Ratio
6.63
Volume
4,000.00
Day High - Low
24.05 - 22.15
52W High-Low
49.70 - 19.60
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
25.92 Cr
EPS
3.67
PE Ratio
6.63
PB Ratio
0.91
Book Value
25.11
EBITDA
6.70
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
13.28
Debt to Equity
0.55
Forecast For
Actual

Company News

View All News
Caret
positive
Medicamen Organics Enters Beauty and Personal Care SectorJun 04, 2025
Medicamen Organics has announced a strategic entry into the beauty and personal care sector. The company is expanding its business portfolio to include beauty and personal care products. No specific details about the products or the scale of this new venture were provided in the news snippet.
positive
Medicamen Organics Invests in Nepalese Manufacturing FacilityDec 24, 2024
Medicamen Organics has made an investment in Medi Hub Organic's manufacturing facility located in Nepal, strengthening its regional presence. This move is expected to enhance the company's production capabilities and expand its market reach in the region.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,801.60
#1 4,32,264.19
39.98
#1 54,729.00
9.71
#1 10,980
16.07
62.14
6,071.00
1,61,165.97
67.21
9,712.00
18.67
2,191
-1.02
38.37
4,390.00
1,48,577.55
66.21
11,539.40
6.99
1,911
26.24
61.73
1,292.30
1,07,859.28
19.93
33,741.20
16.73
5,725
-15.28
51.79
1,314.70
1,06,197.76
23.61
28,409.50
7.12
5,291
-57.18
40.42
2,314.90
1,05,744.36
23.07
22,909.50
13.74
3,306
#1 37.44
57.99
905.90
91,154.74
#1 18.35
23,511.00
18.55
4,615
-0.32
48.43
2,138.90
88,294.88
50.56
12,744.20
#1 20.90
2,007
7.65
47.71
1,296.50
75,300.93
21.89
32,345.60
9.43
3,484
7.59
66.14
5,355.50
64,033.04
26.89
13,458.30
3.70
2,216
1.90
40.57
Growth Rate
Revenue Growth
51.38 %
Net Income Growth
53.85 %
Cash Flow Change
-24.04 %
ROE
-22.79 %
ROCE
-38.67 %
EBITDA Margin (Avg.)
-7.18 %

Yearly Financial Results

Annual Financials
2024
2025
TTM
Revenue
25
38
0
Expenses
21
32
0
EBITDA
5
7
0
Operating Profit %
19 %
17 %
0 %
Depreciation
1
1
0
Interest
1
1
0
Profit Before Tax
4
5
0
Tax
2
1
0
Net Profit
3
4
0
EPS in ₹
3.47
3.67
0.00

Balance Sheet

Balance Sheet
2024
2025
Total Assets
38
59
Fixed Assets
10
10
Current Assets
27
45
Capital Work in Progress
0
2
Investments
0
0
Other Assets
28
47
Total Equity & Liabilities
38
59
Current Liabilities
22
27
Non Current Liabilities
2
2
Total Equity
15
31
Reserve & Surplus
7
18
Share Capital
9
12

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
4
Investing Activities
-0
-2
Operating Activities
-4
-5
Financing Activities
4
11

Share Holding

% Holding
Feb 2024
Jun 2024
Sept 2024
Mar 2025
Sept 2025
Jan 2026
Promoter
81.21 %
59.69 %
59.69 %
59.73 %
59.73 %
61.27 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.07 %
DIIs
0.00 %
0.27 %
0.07 %
0.10 %
0.00 %
3.55 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
13.85 %
28.27 %
28.79 %
30.58 %
28.75 %
Others
18.79 %
26.19 %
11.97 %
11.38 %
9.69 %
6.36 %
No of Share Holders
34
34
379
460
507
515

Technical Indicators

RSI(14)
Neutral
42.84
ATR(14)
Volatile
1.19
STOCH(9,6)
Neutral
29.40
STOCH RSI(14)
Neutral
56.30
MACD(12,26)
Bearish
-0.19
ADX(14)
Weak Trend
16.16
UO(9)
Bearish
48.86
ROC(12)
Downtrend And Accelerating
-11.40
WillR(14)
Neutral
-76.67